Skip to Main Content

Gastrointestinal Medical Oncology Clinic

The UCSF Gastrointestinal Medical Oncology Clinic offers the most advanced and effective treatments available for cancerous as well as benign gastrointestinal conditions. These include conditions involving the anus, bile duct, colon, esophagus, gallbladder, liver, pancreas, peritoneal cavity, rectum, small intestine, spleen and stomach.

Our locations

Expand Map

    Other UCSF cancer care options near you (2)

    UCSF-John Muir Health Cancer Center in Berkeley

    UCSF-John Muir Health Cancer Center in Berkeley

    3100 San Pablo Ave., Suite 280
    Berkeley, CA 94702

    2

    UCSF – Washington Cancer Center

    UCSF – Washington Cancer Center

    See our locations in Fremont.

    Our team

    Patient stories

    Battling cancer during pregnancy

    When Amanda was diagnosed with colon cancer while pregnant, her UCSF doctors found a way to provide the lifesaving care she needed without harm to her baby.

    Early-Onset Colon Cancer

    Colon cancer rates are rising for people under 50. Watch leading doctors discuss possible reasons, risk factors and available treatments.

    Decorative Caduceus

    Pancreatic Cancer Early Detection Consortium

    Diagnosis of PDAC

    Recruiting

    Decorative Caduceus

    A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIR...

    Recruiting

    Decorative Caduceus

    Comparison of Whole Body DWI to FDG PET

    The overall proportion of lesions that will be characterized as positive on whole body (WB) diffusion weight imaging (DWI) and FDG PET.

    Recruiting

    Decorative Caduceus

    Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

    The proportion of patients who achieve a greater than 50% decline from baseline prostate specific antigen (PSA) (PSA50) drawn prior to C1D1, at any point in the treatment course, will be descriptively reported along with 95% binom...

    Recruiting

    Decorative Caduceus

    Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastat...

    PSA progression is defined as a rise in PSA at > 12 weeks by more than 25% and more than 2ng/mL above the nadir (lowest PSA point).

    Recruiting

    Decorative Caduceus

    Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

    ORR is defined as a complete response (CR) or a partial response (PR) according to RECIST version 1.1 criteria. The All Subjects as Treated (ASaT, ITT) population will be used for analysis which consists of all participants who re...

    Recruiting

    Decorative Caduceus

    Addressing the Nutritional Needs of Cancer Survivors With Nutrition Insecurity

    The FIM is a four-item measure of implementation that assesses participants perceived appropriateness of the intervention. Each item response falls on a scale of 1 (Completely disagree) to 5 (Completely agree). A scaled score is c...

    Recruiting

    Decorative Caduceus

    18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

    Sensitivity of 18F-fluorocholine PET for the detection of abnormal parathyroid adenomas confirmed by pathology as compared to sestamibi imaging. Location of parathyroid adenoma at imaging as read by three blinded readers, will be ...

    Recruiting

    Decorative Caduceus

    TheraSphere With Durvalumab and Tremelimumab for HCC

    Complete response and partial response evaluated by mRECIST.

    Recruiting

    Decorative Caduceus

    Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

    To determine the recommended phase II dose (RP2D) hydroxychloroquine in combination with trametinib.

    Recruiting

    U.S. News rankings

    • U S  News and World Report badge recognizing UCSF as part of its 2024-2025 Honor Roll

      Among the top hospitals in the nation

    • U S News and World Report badge recognizing UCSF among the Best Hospitals for Gastroenterology and G I Surgery, 2024-2025

      One of the nation's best for gastroenterology & GI surgery

    • U S News and World Report badge recognizing UCSF among the Best Hospitals for Cancer, 2024-2025

      Best in Northern California and No. 7 in the nation for cancer care

    Accreditations & memberships

    • National Cancer Institute

      The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.

    • Commission on Cancer

      UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.

    • National Comprehensive Cancer Network

      UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.

    Support services

    Preparing for your appointment

    What to Bring

    • Photo I.D.
    • Health insurance card
    • Insurance authorization, if required
    • Doctor's referral, if required
    • Recent test results related to your condition
    • List of your medications, including dosages, plus any you're allergic to
    • List of questions you may have
    • Device or paper for taking notes

    Related clinics

    Our research initiatives

    • UCSF-Helen-Diller-Family-Comprehensive-Cancer-Center-Research-2x

      UCSF Helen Diller Family Comprehensive Cancer Center Research

      UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.

    Can't find what you're looking for?

    UCSF Help Center

    (888) 689-8273

    Share